Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

ASLAN Pharmaceuticals

NASDAQ ASLN
$0.41 -0.0088 -2.14%
Today share price
Singapore
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

180.81M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
186.38M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.49
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
439.93M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-21.28 %

Upcoming events ASLAN Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart ASLAN Pharmaceuticals

Stock analysis ASLAN Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-4.09 27.22
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-13.61 3.54
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
- 9.69
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
- -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
332.81 13.82

Price change ASLAN Pharmaceuticals per year

1.42$ 6.75$
Min Max

Summary analysis ASLAN Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure ASLAN Pharmaceuticals

Revenue and net income ASLAN Pharmaceuticals

All parameters

Stock news ASLAN Pharmaceuticals

All news
6 July 2023 в 15:25

Aslan Pharmaceuticals shares slide amid new data on atopic dermatitis treatment

27 September 2021 в 13:30

Aslan Pharmaceuticals Says Results Positive in Phase 1 Skin-Drug Study

27 September 2021 в 13:30

Aslan Pharmaceuticals Says Results Positive in Phase 1 Skin-Drug Study

4 December 2019 в 13:09

Лидеры и аутсайдеры Уолл-cтрит: LightInTheBox, Aslan Pharmaceuticals, Aqua Metals, Reebonz

About company ASLAN Pharmaceuticals

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.
Address:
83 Clemenceau Avenue, Singapore, Singapore, 239920
Company name: ASLAN Pharmaceuticals
Issuer ticker: ASLN
ISIN: US04522R1014
Country: Singapore
Exchange: NASDAQ
Currency: $
IPO date: 2018-05-04
Sector: Healthcare
Industry: Biotechnology
Site: https://aslanpharma.com

On which stock exchange are ASLAN Pharmaceuticals (ASLN) stocks traded?

ASLAN Pharmaceuticals (ASLN) stocks are traded on NASDAQ.

What is the ticker of ASLAN Pharmaceuticals stocks (ASLN)?

The stock ticker of ASLAN Pharmaceuticals’s stocks or in other words, the code is ASLN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does ASLAN Pharmaceuticals (ASLN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, ASLAN Pharmaceuticals (ASLN) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are ASLAN Pharmaceuticals (ASLN) stocks traded?

ASLAN Pharmaceuticals (ASLN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of ASLAN Pharmaceuticals (ASLN) stocks today?

The current price of ASLAN Pharmaceuticals stocks on 11.05.2024 is 0.411 dollars. per share.

What is the dynamics of ASLAN Pharmaceuticals (ASLN) stocks from the beginning of the year?

ASLAN Pharmaceuticals (ASLN) quotes have increased by -25.27% from the beginning of the year up to 0.411 dollars. per 1 stocks.

How much did ASLAN Pharmaceuticals (ASLN) stocks increase in мае 2024?

This month ASLAN Pharmaceuticals (ASLN) quotes have increased by -10.09% to 0.411 dollars. per share.

How much are ASLAN Pharmaceuticals (ASLN) stocks worth?

Today, on October, 11.05.2024 ASLAN Pharmaceuticals’s (ASLN) stocks cost 0.411 dollars..

What is the market capitalization of ASLAN Pharmaceuticals (ASLN)?

Capitalization is the market value of ASLAN Pharmaceuticals (ASLN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of ASLAN Pharmaceuticals (ASLN) is estimated at about 180809783 dollars.